World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Generic-Drug Firms Go Beyond Knockoffs
Keywords:
Teva Pharmaceutical and at-risk launches of generic drugs
06/15/2013
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Wall Street Journal 10/31/2013
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Teva Pharmaceuticals Hit by Increased Competition in U.S. Generics
WSJ 08/03/2017
Teva Pharmaceutical's strategy
05/12/2011
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Wall Street Journal 10/11/2013
Wall Street Journal 10/31/2013
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Threat of Generic Copycat Comes Back to Nip at Teva
Wall Street Journal 07/25/2011
Ranbaxy strategies
06/15/2013
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Daiichi Sankyo to Sell Troubled Ranbaxy
Wall Street Journal 04/08/2014
A different patent cliff facing generics drug makers
12/03/2012
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Generic Drug Makers Facing Squeeze on Revenue
New York Times 12/03/2012
Indian generic phamaceutical company Lupin
09/29/2011
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Lupin Sees U.S. Generic-Drug Pickup
Wall Street Journal 09/29/2011
Top Court in India Rejects Novartis Drug Patent
New York Times 04/01/2013
Pharmaceutical Generics.
10/22/2006
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
More Low-Cost Generics - WSJ.com
Wall Street Journal 10/22/2006
For Booming Biotech Firms, A New Threat: Generics
Wall Street Journal 03/14/2007
In Trade Deal, a Shift on Generics
Wall Street Journal 05/17/2007
Wall Street Journal 02/06/2008
Daiichi Targets Generics to Extend Reach
Wall Street Journal 06/12/2008
Teva Pharmaceutical financial performance- 2011-2015
05/12/2011
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Wall Street Journal 10/11/2013
Wall Street Journal 10/31/2013
Mylan Rejects Teva’s $40 Billion Takeover Offer
New York Times 04/27/2015
Teva Poised to Get a Big Boost in Generics
Wall Street Journal 07/27/2015
Wall Street Journal 05/12/2011
Indian pharmaceutical manufacturer Ranbaxy performance
03/06/2012
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Daiichi Sankyo to Sell Troubled Ranbaxy
Wall Street Journal 04/08/2014
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
Generic Drug Makers Facing Squeeze on Revenue
New York Times 12/03/2012
Ranbaxy management
06/15/2013
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Daiichi Sankyo to Sell Troubled Ranbaxy
Wall Street Journal 04/08/2014
Amgen partnership with generics manufacturer Watson Pharmaceuticals
10/22/2006
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Amgen and Watson to Work Together on Generic Drugs
New York Times 12/19/2011
Wall Street Journal 04/23/2012
More Low-Cost Generics - WSJ.com
Wall Street Journal 10/22/2006
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
Pharmaceutical companies fighting generics.
10/22/2006
Pharmaceutical compaies are trying to make it harder for pharmacists to substitute generics.
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Industry Fights Switch To Generics for Epilepsy
Wall Street Journal 07/13/2007
Wall Street Journal 02/06/2008
TriCor Case May Illuminate Patent Limits
Wall Street Journal 06/02/2008
How a Drug Maker Tries to Outwit Generics
Wall Street Journal 11/17/2008
Ending the Silence of Generic Drugmakers
BusinessWeek 06/24/2010
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us